- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Antibody discovery platforms have emerged in recent years as an important source of both therapeutic molecules and research reagents.
According to our latest study, the global Therapeutic Antibody Discovery Platform market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Therapeutic Antibody Discovery Platform market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Therapeutic Antibody Discovery Platform market size and forecasts, in consumption value ($ Million), 2018-2029
Global Therapeutic Antibody Discovery Platform market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Therapeutic Antibody Discovery Platform market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Therapeutic Antibody Discovery Platform market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Therapeutic Antibody Discovery Platform
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Therapeutic Antibody Discovery Platform market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abveris, YUMAB, Ablexis, AvantGen and OXGENE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Therapeutic Antibody Discovery Platform market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Animal
Human
Market segment by Application
Pharmaceutical and Biotechnology Companies
Research Laboratories
Market segment by players, this report covers
Abveris
YUMAB
Ablexis
AvantGen
OXGENE
Evotec
Alacrita
Invetx
Charles River Laboratories
Aerium Therapeutics
Chugai Pharmaceutical
AbCellera
Twist Bioscience
Talem Therapeutics
Bio-Rad
Memo Therapeutics
OmniAb
Antibody Solutions
Lepu Biopharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Therapeutic Antibody Discovery Platform product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Therapeutic Antibody Discovery Platform, with revenue, gross margin and global market share of Therapeutic Antibody Discovery Platform from 2018 to 2023.
Chapter 3, the Therapeutic Antibody Discovery Platform competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Therapeutic Antibody Discovery Platform market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Therapeutic Antibody Discovery Platform.
Chapter 13, to describe Therapeutic Antibody Discovery Platform research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Therapeutic Antibody Discovery Platform
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Therapeutic Antibody Discovery Platform by Type
1.3.1 Overview: Global Therapeutic Antibody Discovery Platform Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Therapeutic Antibody Discovery Platform Consumption Value Market Share by Type in 2022
1.3.3 Animal
1.3.4 Human
1.4 Global Therapeutic Antibody Discovery Platform Market by Application
1.4.1 Overview: Global Therapeutic Antibody Discovery Platform Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical and Biotechnology Companies
1.4.3 Research Laboratories
1.5 Global Therapeutic Antibody Discovery Platform Market Size & Forecast
1.6 Global Therapeutic Antibody Discovery Platform Market Size and Forecast by Region
1.6.1 Global Therapeutic Antibody Discovery Platform Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Therapeutic Antibody Discovery Platform Market Size by Region, (2018-2029)
1.6.3 North America Therapeutic Antibody Discovery Platform Market Size and Prospect (2018-2029)
1.6.4 Europe Therapeutic Antibody Discovery Platform Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Therapeutic Antibody Discovery Platform Market Size and Prospect (2018-2029)
1.6.6 South America Therapeutic Antibody Discovery Platform Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Therapeutic Antibody Discovery Platform Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Abveris
2.1.1 Abveris Details
2.1.2 Abveris Major Business
2.1.3 Abveris Therapeutic Antibody Discovery Platform Product and Solutions
2.1.4 Abveris Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abveris Recent Developments and Future Plans
2.2 YUMAB
2.2.1 YUMAB Details
2.2.2 YUMAB Major Business
2.2.3 YUMAB Therapeutic Antibody Discovery Platform Product and Solutions
2.2.4 YUMAB Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 YUMAB Recent Developments and Future Plans
2.3 Ablexis
2.3.1 Ablexis Details
2.3.2 Ablexis Major Business
2.3.3 Ablexis Therapeutic Antibody Discovery Platform Product and Solutions
2.3.4 Ablexis Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Ablexis Recent Developments and Future Plans
2.4 AvantGen
2.4.1 AvantGen Details
2.4.2 AvantGen Major Business
2.4.3 AvantGen Therapeutic Antibody Discovery Platform Product and Solutions
2.4.4 AvantGen Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 AvantGen Recent Developments and Future Plans
2.5 OXGENE
2.5.1 OXGENE Details
2.5.2 OXGENE Major Business
2.5.3 OXGENE Therapeutic Antibody Discovery Platform Product and Solutions
2.5.4 OXGENE Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 OXGENE Recent Developments and Future Plans
2.6 Evotec
2.6.1 Evotec Details
2.6.2 Evotec Major Business
2.6.3 Evotec Therapeutic Antibody Discovery Platform Product and Solutions
2.6.4 Evotec Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Evotec Recent Developments and Future Plans
2.7 Alacrita
2.7.1 Alacrita Details
2.7.2 Alacrita Major Business
2.7.3 Alacrita Therapeutic Antibody Discovery Platform Product and Solutions
2.7.4 Alacrita Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Alacrita Recent Developments and Future Plans
2.8 Invetx
2.8.1 Invetx Details
2.8.2 Invetx Major Business
2.8.3 Invetx Therapeutic Antibody Discovery Platform Product and Solutions
2.8.4 Invetx Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Invetx Recent Developments and Future Plans
2.9 Charles River Laboratories
2.9.1 Charles River Laboratories Details
2.9.2 Charles River Laboratories Major Business
2.9.3 Charles River Laboratories Therapeutic Antibody Discovery Platform Product and Solutions
2.9.4 Charles River Laboratories Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Charles River Laboratories Recent Developments and Future Plans
2.10 Aerium Therapeutics
2.10.1 Aerium Therapeutics Details
2.10.2 Aerium Therapeutics Major Business
2.10.3 Aerium Therapeutics Therapeutic Antibody Discovery Platform Product and Solutions
2.10.4 Aerium Therapeutics Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Aerium Therapeutics Recent Developments and Future Plans
2.11 Chugai Pharmaceutical
2.11.1 Chugai Pharmaceutical Details
2.11.2 Chugai Pharmaceutical Major Business
2.11.3 Chugai Pharmaceutical Therapeutic Antibody Discovery Platform Product and Solutions
2.11.4 Chugai Pharmaceutical Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Chugai Pharmaceutical Recent Developments and Future Plans
2.12 AbCellera
2.12.1 AbCellera Details
2.12.2 AbCellera Major Business
2.12.3 AbCellera Therapeutic Antibody Discovery Platform Product and Solutions
2.12.4 AbCellera Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 AbCellera Recent Developments and Future Plans
2.13 Twist Bioscience
2.13.1 Twist Bioscience Details
2.13.2 Twist Bioscience Major Business
2.13.3 Twist Bioscience Therapeutic Antibody Discovery Platform Product and Solutions
2.13.4 Twist Bioscience Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Twist Bioscience Recent Developments and Future Plans
2.14 Talem Therapeutics
2.14.1 Talem Therapeutics Details
2.14.2 Talem Therapeutics Major Business
2.14.3 Talem Therapeutics Therapeutic Antibody Discovery Platform Product and Solutions
2.14.4 Talem Therapeutics Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Talem Therapeutics Recent Developments and Future Plans
2.15 Bio-Rad
2.15.1 Bio-Rad Details
2.15.2 Bio-Rad Major Business
2.15.3 Bio-Rad Therapeutic Antibody Discovery Platform Product and Solutions
2.15.4 Bio-Rad Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Bio-Rad Recent Developments and Future Plans
2.16 Memo Therapeutics
2.16.1 Memo Therapeutics Details
2.16.2 Memo Therapeutics Major Business
2.16.3 Memo Therapeutics Therapeutic Antibody Discovery Platform Product and Solutions
2.16.4 Memo Therapeutics Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Memo Therapeutics Recent Developments and Future Plans
2.17 OmniAb
2.17.1 OmniAb Details
2.17.2 OmniAb Major Business
2.17.3 OmniAb Therapeutic Antibody Discovery Platform Product and Solutions
2.17.4 OmniAb Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 OmniAb Recent Developments and Future Plans
2.18 Antibody Solutions
2.18.1 Antibody Solutions Details
2.18.2 Antibody Solutions Major Business
2.18.3 Antibody Solutions Therapeutic Antibody Discovery Platform Product and Solutions
2.18.4 Antibody Solutions Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Antibody Solutions Recent Developments and Future Plans
2.19 Lepu Biopharma
2.19.1 Lepu Biopharma Details
2.19.2 Lepu Biopharma Major Business
2.19.3 Lepu Biopharma Therapeutic Antibody Discovery Platform Product and Solutions
2.19.4 Lepu Biopharma Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Lepu Biopharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Therapeutic Antibody Discovery Platform Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Therapeutic Antibody Discovery Platform by Company Revenue
3.2.2 Top 3 Therapeutic Antibody Discovery Platform Players Market Share in 2022
3.2.3 Top 6 Therapeutic Antibody Discovery Platform Players Market Share in 2022
3.3 Therapeutic Antibody Discovery Platform Market: Overall Company Footprint Analysis
3.3.1 Therapeutic Antibody Discovery Platform Market: Region Footprint
3.3.2 Therapeutic Antibody Discovery Platform Market: Company Product Type Footprint
3.3.3 Therapeutic Antibody Discovery Platform Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Therapeutic Antibody Discovery Platform Consumption Value and Market Share by Type (2018-2023)
4.2 Global Therapeutic Antibody Discovery Platform Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Therapeutic Antibody Discovery Platform Consumption Value Market Share by Application (2018-2023)
5.2 Global Therapeutic Antibody Discovery Platform Market Forecast by Application (2024-2029)
6 North America
6.1 North America Therapeutic Antibody Discovery Platform Consumption Value by Type (2018-2029)
6.2 North America Therapeutic Antibody Discovery Platform Consumption Value by Application (2018-2029)
6.3 North America Therapeutic Antibody Discovery Platform Market Size by Country
6.3.1 North America Therapeutic Antibody Discovery Platform Consumption Value by Country (2018-2029)
6.3.2 United States Therapeutic Antibody Discovery Platform Market Size and Forecast (2018-2029)
6.3.3 Canada Therapeutic Antibody Discovery Platform Market Size and Forecast (2018-2029)
6.3.4 Mexico Therapeutic Antibody Discovery Platform Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Therapeutic Antibody Discovery Platform Consumption Value by Type (2018-2029)
7.2 Europe Therapeutic Antibody Discovery Platform Consumption Value by Application (2018-2029)
7.3 Europe Therapeutic Antibody Discovery Platform Market Size by Country
7.3.1 Europe Therapeutic Antibody Discovery Platform Consumption Value by Country (2018-2029)
7.3.2 Germany Therapeutic Antibody Discovery Platform Market Size and Forecast (2018-2029)
7.3.3 France Therapeutic Antibody Discovery Platform Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Therapeutic Antibody Discovery Platform Market Size and Forecast (2018-2029)
7.3.5 Russia Therapeutic Antibody Discovery Platform Market Size and Forecast (2018-2029)
7.3.6 Italy Therapeutic Antibody Discovery Platform Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Antibody Discovery Platform Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Therapeutic Antibody Discovery Platform Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Therapeutic Antibody Discovery Platform Market Size by Region
8.3.1 Asia-Pacific Therapeutic Antibody Discovery Platform Consumption Value by Region (2018-2029)
8.3.2 China Therapeutic Antibody Discovery Platform Market Size and Forecast (2018-2029)
8.3.3 Japan Therapeutic Antibody Discovery Platform Market Size and Forecast (2018-2029)
8.3.4 South Korea Therapeutic Antibody Discovery Platform Market Size and Forecast (2018-2029)
8.3.5 India Therapeutic Antibody Discovery Platform Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Therapeutic Antibody Discovery Platform Market Size and Forecast (2018-2029)
8.3.7 Australia Therapeutic Antibody Discovery Platform Market Size and Forecast (2018-2029)
9 South America
9.1 South America Therapeutic Antibody Discovery Platform Consumption Value by Type (2018-2029)
9.2 South America Therapeutic Antibody Discovery Platform Consumption Value by Application (2018-2029)
9.3 South America Therapeutic Antibody Discovery Platform Market Size by Country
9.3.1 South America Therapeutic Antibody Discovery Platform Consumption Value by Country (2018-2029)
9.3.2 Brazil Therapeutic Antibody Discovery Platform Market Size and Forecast (2018-2029)
9.3.3 Argentina Therapeutic Antibody Discovery Platform Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Antibody Discovery Platform Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Therapeutic Antibody Discovery Platform Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Therapeutic Antibody Discovery Platform Market Size by Country
10.3.1 Middle East & Africa Therapeutic Antibody Discovery Platform Consumption Value by Country (2018-2029)
10.3.2 Turkey Therapeutic Antibody Discovery Platform Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Therapeutic Antibody Discovery Platform Market Size and Forecast (2018-2029)
10.3.4 UAE Therapeutic Antibody Discovery Platform Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Therapeutic Antibody Discovery Platform Market Drivers
11.2 Therapeutic Antibody Discovery Platform Market Restraints
11.3 Therapeutic Antibody Discovery Platform Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Therapeutic Antibody Discovery Platform Industry Chain
12.2 Therapeutic Antibody Discovery Platform Upstream Analysis
12.3 Therapeutic Antibody Discovery Platform Midstream Analysis
12.4 Therapeutic Antibody Discovery Platform Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Therapeutic Antibody Discovery Platform Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Therapeutic Antibody Discovery Platform Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Therapeutic Antibody Discovery Platform Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Therapeutic Antibody Discovery Platform Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Abveris Company Information, Head Office, and Major Competitors
Table 6. Abveris Major Business
Table 7. Abveris Therapeutic Antibody Discovery Platform Product and Solutions
Table 8. Abveris Therapeutic Antibody Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Abveris Recent Developments and Future Plans
Table 10. YUMAB Company Information, Head Office, and Major Competitors
Table 11. YUMAB Major Business
Table 12. YUMAB Therapeutic Antibody Discovery Platform Product and Solutions
Table 13. YUMAB Therapeutic Antibody Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. YUMAB Recent Developments and Future Plans
Table 15. Ablexis Company Information, Head Office, and Major Competitors
Table 16. Ablexis Major Business
Table 17. Ablexis Therapeutic Antibody Discovery Platform Product and Solutions
Table 18. Ablexis Therapeutic Antibody Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Ablexis Recent Developments and Future Plans
Table 20. AvantGen Company Information, Head Office, and Major Competitors
Table 21. AvantGen Major Business
Table 22. AvantGen Therapeutic Antibody Discovery Platform Product and Solutions
Table 23. AvantGen Therapeutic Antibody Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. AvantGen Recent Developments and Future Plans
Table 25. OXGENE Company Information, Head Office, and Major Competitors
Table 26. OXGENE Major Business
Table 27. OXGENE Therapeutic Antibody Discovery Platform Product and Solutions
Table 28. OXGENE Therapeutic Antibody Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. OXGENE Recent Developments and Future Plans
Table 30. Evotec Company Information, Head Office, and Major Competitors
Table 31. Evotec Major Business
Table 32. Evotec Therapeutic Antibody Discovery Platform Product and Solutions
Table 33. Evotec Therapeutic Antibody Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Evotec Recent Developments and Future Plans
Table 35. Alacrita Company Information, Head Office, and Major Competitors
Table 36. Alacrita Major Business
Table 37. Alacrita Therapeutic Antibody Discovery Platform Product and Solutions
Table 38. Alacrita Therapeutic Antibody Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Alacrita Recent Developments and Future Plans
Table 40. Invetx Company Information, Head Office, and Major Competitors
Table 41. Invetx Major Business
Table 42. Invetx Therapeutic Antibody Discovery Platform Product and Solutions
Table 43. Invetx Therapeutic Antibody Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Invetx Recent Developments and Future Plans
Table 45. Charles River Laboratories Company Information, Head Office, and Major Competitors
Table 46. Charles River Laboratories Major Business
Table 47. Charles River Laboratories Therapeutic Antibody Discovery Platform Product and Solutions
Table 48. Charles River Laboratories Therapeutic Antibody Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Charles River Laboratories Recent Developments and Future Plans
Table 50. Aerium Therapeutics Company Information, Head Office, and Major Competitors
Table 51. Aerium Therapeutics Major Business
Table 52. Aerium Therapeutics Therapeutic Antibody Discovery Platform Product and Solutions
Table 53. Aerium Therapeutics Therapeutic Antibody Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Aerium Therapeutics Recent Developments and Future Plans
Table 55. Chugai Pharmaceutical Company Information, Head Office, and Major Competitors
Table 56. Chugai Pharmaceutical Major Business
Table 57. Chugai Pharmaceutical Therapeutic Antibody Discovery Platform Product and Solutions
Table 58. Chugai Pharmaceutical Therapeutic Antibody Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Chugai Pharmaceutical Recent Developments and Future Plans
Table 60. AbCellera Company Information, Head Office, and Major Competitors
Table 61. AbCellera Major Business
Table 62. AbCellera Therapeutic Antibody Discovery Platform Product and Solutions
Table 63. AbCellera Therapeutic Antibody Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. AbCellera Recent Developments and Future Plans
Table 65. Twist Bioscience Company Information, Head Office, and Major Competitors
Table 66. Twist Bioscience Major Business
Table 67. Twist Bioscience Therapeutic Antibody Discovery Platform Product and Solutions
Table 68. Twist Bioscience Therapeutic Antibody Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Twist Bioscience Recent Developments and Future Plans
Table 70. Talem Therapeutics Company Information, Head Office, and Major Competitors
Table 71. Talem Therapeutics Major Business
Table 72. Talem Therapeutics Therapeutic Antibody Discovery Platform Product and Solutions
Table 73. Talem Therapeutics Therapeutic Antibody Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Talem Therapeutics Recent Developments and Future Plans
Table 75. Bio-Rad Company Information, Head Office, and Major Competitors
Table 76. Bio-Rad Major Business
Table 77. Bio-Rad Therapeutic Antibody Discovery Platform Product and Solutions
Table 78. Bio-Rad Therapeutic Antibody Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Bio-Rad Recent Developments and Future Plans
Table 80. Memo Therapeutics Company Information, Head Office, and Major Competitors
Table 81. Memo Therapeutics Major Business
Table 82. Memo Therapeutics Therapeutic Antibody Discovery Platform Product and Solutions
Table 83. Memo Therapeutics Therapeutic Antibody Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Memo Therapeutics Recent Developments and Future Plans
Table 85. OmniAb Company Information, Head Office, and Major Competitors
Table 86. OmniAb Major Business
Table 87. OmniAb Therapeutic Antibody Discovery Platform Product and Solutions
Table 88. OmniAb Therapeutic Antibody Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. OmniAb Recent Developments and Future Plans
Table 90. Antibody Solutions Company Information, Head Office, and Major Competitors
Table 91. Antibody Solutions Major Business
Table 92. Antibody Solutions Therapeutic Antibody Discovery Platform Product and Solutions
Table 93. Antibody Solutions Therapeutic Antibody Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Antibody Solutions Recent Developments and Future Plans
Table 95. Lepu Biopharma Company Information, Head Office, and Major Competitors
Table 96. Lepu Biopharma Major Business
Table 97. Lepu Biopharma Therapeutic Antibody Discovery Platform Product and Solutions
Table 98. Lepu Biopharma Therapeutic Antibody Discovery Platform Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Lepu Biopharma Recent Developments and Future Plans
Table 100. Global Therapeutic Antibody Discovery Platform Revenue (USD Million) by Players (2018-2023)
Table 101. Global Therapeutic Antibody Discovery Platform Revenue Share by Players (2018-2023)
Table 102. Breakdown of Therapeutic Antibody Discovery Platform by Company Type (Tier 1, Tier 2, and Tier 3)
Table 103. Market Position of Players in Therapeutic Antibody Discovery Platform, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 104. Head Office of Key Therapeutic Antibody Discovery Platform Players
Table 105. Therapeutic Antibody Discovery Platform Market: Company Product Type Footprint
Table 106. Therapeutic Antibody Discovery Platform Market: Company Product Application Footprint
Table 107. Therapeutic Antibody Discovery Platform New Market Entrants and Barriers to Market Entry
Table 108. Therapeutic Antibody Discovery Platform Mergers, Acquisition, Agreements, and Collaborations
Table 109. Global Therapeutic Antibody Discovery Platform Consumption Value (USD Million) by Type (2018-2023)
Table 110. Global Therapeutic Antibody Discovery Platform Consumption Value Share by Type (2018-2023)
Table 111. Global Therapeutic Antibody Discovery Platform Consumption Value Forecast by Type (2024-2029)
Table 112. Global Therapeutic Antibody Discovery Platform Consumption Value by Application (2018-2023)
Table 113. Global Therapeutic Antibody Discovery Platform Consumption Value Forecast by Application (2024-2029)
Table 114. North America Therapeutic Antibody Discovery Platform Consumption Value by Type (2018-2023) & (USD Million)
Table 115. North America Therapeutic Antibody Discovery Platform Consumption Value by Type (2024-2029) & (USD Million)
Table 116. North America Therapeutic Antibody Discovery Platform Consumption Value by Application (2018-2023) & (USD Million)
Table 117. North America Therapeutic Antibody Discovery Platform Consumption Value by Application (2024-2029) & (USD Million)
Table 118. North America Therapeutic Antibody Discovery Platform Consumption Value by Country (2018-2023) & (USD Million)
Table 119. North America Therapeutic Antibody Discovery Platform Consumption Value by Country (2024-2029) & (USD Million)
Table 120. Europe Therapeutic Antibody Discovery Platform Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Europe Therapeutic Antibody Discovery Platform Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Europe Therapeutic Antibody Discovery Platform Consumption Value by Application (2018-2023) & (USD Million)
Table 123. Europe Therapeutic Antibody Discovery Platform Consumption Value by Application (2024-2029) & (USD Million)
Table 124. Europe Therapeutic Antibody Discovery Platform Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Therapeutic Antibody Discovery Platform Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Therapeutic Antibody Discovery Platform Consumption Value by Type (2018-2023) & (USD Million)
Table 127. Asia-Pacific Therapeutic Antibody Discovery Platform Consumption Value by Type (2024-2029) & (USD Million)
Table 128. Asia-Pacific Therapeutic Antibody Discovery Platform Consumption Value by Application (2018-2023) & (USD Million)
Table 129. Asia-Pacific Therapeutic Antibody Discovery Platform Consumption Value by Application (2024-2029) & (USD Million)
Table 130. Asia-Pacific Therapeutic Antibody Discovery Platform Consumption Value by Region (2018-2023) & (USD Million)
Table 131. Asia-Pacific Therapeutic Antibody Discovery Platform Consumption Value by Region (2024-2029) & (USD Million)
Table 132. South America Therapeutic Antibody Discovery Platform Consumption Value by Type (2018-2023) & (USD Million)
Table 133. South America Therapeutic Antibody Discovery Platform Consumption Value by Type (2024-2029) & (USD Million)
Table 134. South America Therapeutic Antibody Discovery Platform Consumption Value by Application (2018-2023) & (USD Million)
Table 135. South America Therapeutic Antibody Discovery Platform Consumption Value by Application (2024-2029) & (USD Million)
Table 136. South America Therapeutic Antibody Discovery Platform Consumption Value by Country (2018-2023) & (USD Million)
Table 137. South America Therapeutic Antibody Discovery Platform Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Middle East & Africa Therapeutic Antibody Discovery Platform Consumption Value by Type (2018-2023) & (USD Million)
Table 139. Middle East & Africa Therapeutic Antibody Discovery Platform Consumption Value by Type (2024-2029) & (USD Million)
Table 140. Middle East & Africa Therapeutic Antibody Discovery Platform Consumption Value by Application (2018-2023) & (USD Million)
Table 141. Middle East & Africa Therapeutic Antibody Discovery Platform Consumption Value by Application (2024-2029) & (USD Million)
Table 142. Middle East & Africa Therapeutic Antibody Discovery Platform Consumption Value by Country (2018-2023) & (USD Million)
Table 143. Middle East & Africa Therapeutic Antibody Discovery Platform Consumption Value by Country (2024-2029) & (USD Million)
Table 144. Therapeutic Antibody Discovery Platform Raw Material
Table 145. Key Suppliers of Therapeutic Antibody Discovery Platform Raw Materials
List of Figures
Figure 1. Therapeutic Antibody Discovery Platform Picture
Figure 2. Global Therapeutic Antibody Discovery Platform Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Therapeutic Antibody Discovery Platform Consumption Value Market Share by Type in 2022
Figure 4. Animal
Figure 5. Human
Figure 6. Global Therapeutic Antibody Discovery Platform Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Therapeutic Antibody Discovery Platform Consumption Value Market Share by Application in 2022
Figure 8. Pharmaceutical and Biotechnology Companies Picture
Figure 9. Research Laboratories Picture
Figure 10. Global Therapeutic Antibody Discovery Platform Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Therapeutic Antibody Discovery Platform Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Market Therapeutic Antibody Discovery Platform Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 13. Global Therapeutic Antibody Discovery Platform Consumption Value Market Share by Region (2018-2029)
Figure 14. Global Therapeutic Antibody Discovery Platform Consumption Value Market Share by Region in 2022
Figure 15. North America Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 16. Europe Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 17. Asia-Pacific Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 18. South America Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 19. Middle East and Africa Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 20. Global Therapeutic Antibody Discovery Platform Revenue Share by Players in 2022
Figure 21. Therapeutic Antibody Discovery Platform Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 22. Global Top 3 Players Therapeutic Antibody Discovery Platform Market Share in 2022
Figure 23. Global Top 6 Players Therapeutic Antibody Discovery Platform Market Share in 2022
Figure 24. Global Therapeutic Antibody Discovery Platform Consumption Value Share by Type (2018-2023)
Figure 25. Global Therapeutic Antibody Discovery Platform Market Share Forecast by Type (2024-2029)
Figure 26. Global Therapeutic Antibody Discovery Platform Consumption Value Share by Application (2018-2023)
Figure 27. Global Therapeutic Antibody Discovery Platform Market Share Forecast by Application (2024-2029)
Figure 28. North America Therapeutic Antibody Discovery Platform Consumption Value Market Share by Type (2018-2029)
Figure 29. North America Therapeutic Antibody Discovery Platform Consumption Value Market Share by Application (2018-2029)
Figure 30. North America Therapeutic Antibody Discovery Platform Consumption Value Market Share by Country (2018-2029)
Figure 31. United States Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 32. Canada Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 33. Mexico Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 34. Europe Therapeutic Antibody Discovery Platform Consumption Value Market Share by Type (2018-2029)
Figure 35. Europe Therapeutic Antibody Discovery Platform Consumption Value Market Share by Application (2018-2029)
Figure 36. Europe Therapeutic Antibody Discovery Platform Consumption Value Market Share by Country (2018-2029)
Figure 37. Germany Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 38. France Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 39. United Kingdom Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 40. Russia Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 41. Italy Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 42. Asia-Pacific Therapeutic Antibody Discovery Platform Consumption Value Market Share by Type (2018-2029)
Figure 43. Asia-Pacific Therapeutic Antibody Discovery Platform Consumption Value Market Share by Application (2018-2029)
Figure 44. Asia-Pacific Therapeutic Antibody Discovery Platform Consumption Value Market Share by Region (2018-2029)
Figure 45. China Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 46. Japan Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 47. South Korea Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 48. India Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 49. Southeast Asia Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 50. Australia Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 51. South America Therapeutic Antibody Discovery Platform Consumption Value Market Share by Type (2018-2029)
Figure 52. South America Therapeutic Antibody Discovery Platform Consumption Value Market Share by Application (2018-2029)
Figure 53. South America Therapeutic Antibody Discovery Platform Consumption Value Market Share by Country (2018-2029)
Figure 54. Brazil Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 55. Argentina Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 56. Middle East and Africa Therapeutic Antibody Discovery Platform Consumption Value Market Share by Type (2018-2029)
Figure 57. Middle East and Africa Therapeutic Antibody Discovery Platform Consumption Value Market Share by Application (2018-2029)
Figure 58. Middle East and Africa Therapeutic Antibody Discovery Platform Consumption Value Market Share by Country (2018-2029)
Figure 59. Turkey Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 60. Saudi Arabia Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 61. UAE Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 62. Therapeutic Antibody Discovery Platform Market Drivers
Figure 63. Therapeutic Antibody Discovery Platform Market Restraints
Figure 64. Therapeutic Antibody Discovery Platform Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Therapeutic Antibody Discovery Platform in 2022
Figure 67. Manufacturing Process Analysis of Therapeutic Antibody Discovery Platform
Figure 68. Therapeutic Antibody Discovery Platform Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
